EDGAR Filing Documents for 0001787306-24-000124

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001787306-24-000124

Filing Date

2024-08-14

Accepted

2024-08-14 16:12:23

Documents

Period of Report

2024-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	arqt-20240630.htm iXBRL	10-Q	1060432
2	EX-10.1	exhibit101secondamendmentt.htm	EX-10.1	752945
3	EX-31.1	exhibit311ceoq22024.htm	EX-31.1	10831
4	EX-31.2	exhibit312cfoq22024.htm	EX-31.2	10792
5	EX-32.1	exhibit321ceocfoq22024.htm	EX-32.1	6983
	Complete submission text file	0001787306-24-000124.txt		6931339

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	arqt-20240630.xsd	EX-101.SCH	42663
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	arqt-20240630_cal.xml	EX-101.CAL	59848
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	arqt-20240630_def.xml	EX-101.DEF	200202
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	arqt-20240630_lab.xml	EX-101.LAB	602823
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	arqt-20240630_pre.xml	EX-101.PRE	411098
70	EXTRACTED XBRL INSTANCE DOCUMENT	arqt-20240630_htm.xml	XML	744784

Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361

Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006

Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)